Preliminary Program
Special meeting - Pre-Conference
Wednesday, September 9 (2:00 - 4:30 PM)
Unique challenges and unmet needs for the treatment of ocular surface disease in various regions of the world
Moderators – Di Chen (China), Arturo Grau Diez (Chile), Sarah Farrant (UK)
Opening remarks – Piera Versura (Italy)
Introduction
The importance of understanding the unmet needs for the treatment of ocular surface diseases throughout the world – Monica Alves (Brazil)
Presentations
North America (i.e. USA and Canada) - Todd Margolis (USA)
Latin America - Juan Carlos Abad (Colombia)
Europe - Jelle Vehof (The Netherlands)
Africa - Sihem Lazreg (Algeria)
Asia – Shigeru Kinoshita (Japan)
Oceania - Fiona Stapleton (Australia)
Synopsis and closing remarks – Eric Papas (Australia)
TFOS 2020 Conference
Thursday, September 10
Opening remarks - Stefano Barabino (Italy)
Conference Address
Moderator – Stefano Barabino (Italy)
A Lifestyle Epidemic: Ocular Surface Disease – Jennifer P Craig (New Zealand)
Session 1. Ocular surface disease: What we do to ourselves
Moderators: Leslie O’Dell (USA), Bridgitte Shen Lee (USA)
Cosmetics - Alison Ng (Canada)
Digital eye strain - James Wolffsohn (UK)
External environment (e.g. pollution, humidity, sick building syndrome, airconditioning/heating) – Louis Tong (Singapore)
Contact lenses – Mark Willcox (Australia)
Depression and stress – Choun-Ki Joo (South Korea)
Age - Kazuo Tsubota (Japan)
Session 2. East, West, North, South: Impact of geographic region and ethnicity on the prevalence and management of ocular surface disease
Moderators - Vatinee Bunya (USA), Afsun Sahin (Turkey)
Fuchs endothelial corneal dystrophy and corneal endothelial diseases - Jodhbir Mehta (Singapore)
Keratoconus – Farhad Hafezi (Switzerland)
Dry eye disease - Michael TM Wang (New Zealand)
Ocular Allergy – Andrea Leonardi (Italy)
Uncorrected refractive error – Lixia Lou (China)
Pterygium - José Gomes (Brazil)
Session 3. New insights into the pathophysiology and management of catastrophic ocular surface diseases
Moderators – Takashi Kojima (Japan), Kyung Chul Yoon (South Korea)
Corneal ulcers (e.g. due to bacterial, fungal and parasitic infections) – James Chodosh (USA)
Ocular chemical injuries - Geetha Iyer (India)
Graft versus host disease - Victor L Perez Quinones (USA)
Stevens-Johnson syndrome/toxic epidermal necrolysis - Hajirah Saeed (USA)
Neurotrophic keratopathy – Harminder Dua (UK)
Ocular surface tumors – Carol L Karp (USA)
Session 4. Seeing differently: The meaning of blindness
Moderators – Gerd Geerling (Germany), José Benitez del Castillo Sanchez (Spain)
Seeing differently: A blind person's perspective on the meaning of blindness - Deborah Tramentozzi (Italy)
Seeing differently: A clinician's perspective on the meaning of blindness – Lotfi Merabet (USA)
Session 5. New approaches for the diagnosis and/or treatment of ocular surface diseases
Moderators – Georgios Kontadakis (Greece), Edoardo Villani (Italy)
An algorithm for the preoperative diagnosis and treatment of ocular surface disorders – Christopher E Starr (USA)
Use of exosomes for cornea wound healing - Ali Djalilian (USA)
Liquid cornea - Virender Sangwan (India)
Thymosin b4: Resurrection of a small, yet powerful, protein in the treatment of bacterial keratitis - Elizabeth Berger (USA)
Proteoglycan 4: Impact on the ocular surface and beyond - Tannin Schmidt (USA)
Restoring ocular surface homeostasis through alteration of autophagy - Gordon Laurie (USA)
Poster Session 1
Moderators – Enesa Begovic (Bosnia), Adriana Stanila (Romania)
TFOS i2 Innovation Showcase (early evening)
Moderator – David A Sullivan (USA)
Introduction (4 minutes) – Amy Gallant Sullivan (USA)
Startup company presentations – each 3 minutes, 2 minutes discussion
Friday, September 11
Session 6. Meibomian gland dysfunction update
Moderators - Anthony Bron (UK), Donald Korb (USA)
The prevalence of meibomian gland dysfunction in adults – Jutta Horwath-Winter (Austria)
Prevalence of meibomian gland atrophy in a pediatric population – Preeya Gupta (USA)
Distribution and Characteristics of Meibomian Gland Dysfunction Subtypes – Kyung-Sun Na (South Korea)
Hyperlipidemia induces meibomian gland dysfunction – Wei Li (China)
The role of fibrosis in meibomian gland dysfunction – Christophe Baudouin (France)
Meibomian gland regeneration (hypoxia, ECM & stem cells) - Yang Liu (USA)
Session 7. Possible treatments for meibomian gland dysfunction - What are the data?
Moderator – Kaevalin Lekhanont (Thailand), Kelly Nichols (USA)
Intraductal probing – Joseph Ciolino (USA)
Thermal pulsation – Allister G Gibbons (USA)
Intense pulsed light therapy– Joanne Shen (USA)
Microbelpharon exfoliation – Jaya Siddireddy (Australia)
Eyelid warming devices - William Ngo (Canada)
Quantum molecular resonance electrotherapy - Giulio Ferrari (Italy)
Session 8. Models and biomarkers for ocular surface disease
Moderators – Benjamin Sullivan (USA), Piera Versura (Italy)
Multiscale reverse engineering of the human ocular surface - Jeongyun Seo (USA/Korea)
Key integrator in the lacrimal gland-cornea feedback loop - Alison Kuony (Finland)
Neutrophils, the meibomian gland and a chronic inflammatory model of allergic eye disease – Daniel R Saban (USA)
Role of lymphangiogenesis in the regulation of corneal edema and transparency - Claus Cursiefen (Germany)
Utility of tear biomarkers for ocular surface and systemic diseases – Sarah Hamm-Alvarez (USA)
Regulatory and Developmental Aspects of Biomarkers in the Treatment of Ocular Surface Disease
– Gary Novack (USA)
Session 9. Did you know?
Moderators – Pasquale Aragona (Italy), Jesús Merayo-Lloves (Spain)
Convergence of artificial intelligence and microelectronics with ocular surface biology and disease – Dimitri Azar (USA)
Disruptive contact lens technologies – Lyndon Jones (Canada)
The multifaceted role of galectin-3 on the ocular surface – Pablo Argueso (USA)
Primum non nocere: The challenge of iatrogenic ocular surface disease – Christina Grupcheva (Bulgaria)
Glaucoma treatment: The bane of the ocular surface – Stefano Bonini (Italy)
What happens when corneal epithelial cells become stressed? - W Gregory Sawyer (USA)
Session 10. Risk factors for dry eye disease - What are the data?
Moderators – Blanka Golebiowski (Australia), Paul Karpecki (USA)
Sleep disorders – Masahiko Ayaki (Japan)
Diabetes – Danielle Robertson (USA)
Office environment – Murat Dogru (Australia)
Oral contraceptives – Meng C Lin (USA)
Demodex - Alex Muntz (New Zealand)
Vitamin D-deficiency - James McMillan (USA)
Poster Session 2
Moderators – Heiko Pult (Germany), Scott Schachter (USA)
Saturday, September 12
Session 11. Debate
Moderators – Etty Bitton (Canada), Maria Markoulli (Australia)
Are omega-3 supplements for treating dry eye an e-fish-ent approach or is the evidence de-fish-ent?
De-fish-ent – Penny Asbell (USA)
E-fish-ent – Laurie Downie (Australia)
Session 12. Limbal stem cell deficiency
Moderators – Paolo Rama (Italy), Shigeto Shimmura (Japan)
The promise and challenge of stem cells in regenerative medicine - Graziella Pellegrini (Italy)
Homeostasis of the corneal stem cell niche from a single cell analysis prospective - Majlinda Lako (UK)
Monitoring the activity of limbal stem cells during development, health, disease and after transplantation – Nick Di Girolamo (Australia)
Diagnosis and staging of limbal stem cell deficiency - Sophie Deng (USA)
Advances in the treatment of limbal stem cell deficiency - Sayan Basu (India)
Bioengineered cornea construct - Julie Daniels (UK)
Session 13. What a nerve!
Moderators – Carlos Belmonte (Spain), Jason Nichols (USA)
What is neuropathic pain, and what are the underlying mechanisms? – Anat Galor (USA)
Neuropathic disease beyond the eye - Peter Reeh (Germany)
Pain and neuroimmune cell interactions - Marzia Malcangio (UK)
Management of neuropathic pain – Pedram Hamrah (USA)
Corneal nerve regeneration in dry eye disease - Sarah Knox (USA)
Does a viral infection make you blink? - Anthony St Leger (USA)
Session 14. Targeting the immune system
Moderators – Esen Akpek (USA), Kyoung Yul Seo (South Korea)
Requirement for type I interferon signaling in lacrimal gland autoimmune disease – Scott Lieberman (USA)
Neurological and inflammatory manifestations in Sjögren's syndrome: The role of the kynurenine metabolic pathway - Eduardo Rocha (Brazil)
The mucosal surfaces of both eyes are immunologically linked by a neurogenic inflammatory reflex – Jeremias Galletti (Argentina)
Neutrophil extracellular traps – Sandeep Jain (USA)
Anti-inflammatory and anti-fibrotic effects of human amniotic membrane mesenchymal stem cells – Alejandro Navas (Mexico)
Research priorities for innovation and translation in allergic diseases – Sergio Bonini (Italy)
Session 15. The microbiome: Do we need to keep an eye on it?
Moderators – Eisuke Shimizu (Japan), Jerome Ozkan (Australia)
How and when is symbiosis of a human host with their microbiota established? – Marcus C de Goffau (UK)
Visions of eye commensals: The known and the unknown about how the microbiome affects eye disease - Rachel Caspi (USA)
Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA– Mihaela Gadjeva (USA)
Protective role of commensal bacteria in Sjögren syndrome - Cintia de Paiva (USA)
Nerves (TRPA1) prevent bacterial adhesion to the corneal surface – Suzi Fleiszig (USA)
Do adenoviruses repurpose bacterial recombination machinery? – Jaya Rajaiya (USA)
Poster Session 3
Moderators – Cecilia Marini (Argentina), Elisabeth Messmer (Germany)
Closing remarks - David A Sullivan (USA)
Deadlines
Abstract-Thema
01.06.2020 | Hinweis
Young investigators applying for a Travel Award should submit their Conference abstract no later than Monday, June 1, 2020. Individuals may apply for this Award without first registering for the Conference. Winners will be notified by Monday, June 15, 2020.
Please note that you need to register for the Conference BEFORE sending your Abstract! Abstracts must be submitted via the online form. We will not accept abstracts via email. Submission instructions are available upon conference registration. |
Abstract
26.06.2020 | Hinweis
All abstracts, except those from Travel Award applicants, must be submitted no later than Friday, June 26, 2020. We will let first authors know if their abstract was accepted within two weeks after abstract submission. All submitted abstracts, except those from invited speakers, will be assigned as poster presentations.
Please note that you need to register for the Conference BEFORE sending your Abstract! Abstracts must be submitted via the online form. We will not accept abstracts via email. Submission instructions are available upon conference registration. |
580
Sun Pharma